A detailed history of Shayne & Co., LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Shayne & Co., LLC holds 39,513 shares of BMY stock, worth $2.27 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
39,513
Previous 39,417 0.24%
Holding current value
$2.27 Million
Previous $1.64 Million 24.94%
% of portfolio
0.52%
Previous 0.46%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$39.66 - $51.75 $3,807 - $4,968
96 Added 0.24%
39,513 $2.04 Million
Q2 2024

Jul 19, 2024

BUY
$40.25 - $52.99 $1.19 Million - $1.57 Million
29,573 Added 300.42%
39,417 $1.64 Million
Q1 2024

May 08, 2024

BUY
$47.98 - $54.4 $4,366 - $4,950
91 Added 0.93%
9,844 $533,000
Q4 2023

Feb 07, 2024

SELL
$48.48 - $57.85 $25,112 - $29,966
-518 Reduced 5.04%
9,753 $500,000
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $76,299 - $85,314
1,318 Added 14.72%
10,271 $596,000
Q2 2023

Aug 04, 2023

BUY
$63.71 - $70.74 $3,822 - $4,244
60 Added 0.67%
8,953 $572,000
Q1 2023

May 04, 2023

BUY
$65.71 - $74.53 $82,597 - $93,684
1,257 Added 16.46%
8,893 $616,000
Q4 2022

Feb 08, 2023

BUY
$68.48 - $81.09 $3,355 - $3,973
49 Added 0.65%
7,636 $549,000
Q3 2022

Oct 21, 2022

BUY
$0.13 - $76.84 $6 - $3,995
52 Added 0.69%
7,587 $539,000
Q2 2022

Jul 22, 2022

BUY
$72.62 - $79.98 $3,703 - $4,078
51 Added 0.68%
7,535 $580,000
Q1 2022

Apr 25, 2022

BUY
$61.48 - $73.72 $3,565 - $4,275
58 Added 0.78%
7,484 $547,000
Q4 2021

Feb 07, 2022

BUY
$53.63 - $62.52 $155,956 - $181,808
2,908 Added 64.36%
7,426 $463,000
Q3 2021

Oct 27, 2021

BUY
$59.17 - $69.31 $1,715 - $2,009
29 Added 0.65%
4,518 $267,000
Q2 2021

Jul 29, 2021

BUY
$61.91 - $67.42 $1,857 - $2,022
30 Added 0.67%
4,489 $300,000
Q1 2021

Apr 30, 2021

BUY
$59.34 - $66.74 $1,780 - $2,002
30 Added 0.68%
4,459 $281,000
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $1,616 - $1,832
28 Added 0.64%
4,429 $275,000
Q3 2020

Nov 09, 2020

BUY
$57.43 - $63.64 $1,722 - $1,909
30 Added 0.69%
4,401 $265,000
Q2 2020

Aug 07, 2020

BUY
$54.82 - $64.09 $1,589 - $1,858
29 Added 0.67%
4,371 $257,000
Q1 2020

May 05, 2020

BUY
$46.4 - $67.43 $1,206 - $1,753
26 Added 0.6%
4,342 $242,000
Q4 2019

Jan 31, 2020

BUY
$49.21 - $64.19 $1,377 - $1,797
28 Added 0.65%
4,316 $277,000
Q3 2019

Oct 29, 2019

BUY
$42.77 - $50.71 $183,397 - $217,444
4,288 New
4,288 $217,000
Q2 2019

Jul 24, 2019

SELL
$44.62 - $49.34 $188,385 - $208,313
-4,222 Closed
0 $0
Q1 2019

May 03, 2019

BUY
$45.12 - $53.8 $1,353 - $1,614
30 Added 0.72%
4,222 $201,000
Q4 2018

Feb 12, 2019

BUY
$48.76 - $63.23 $1,414 - $1,833
29 Added 0.7%
4,192 $218,000
Q3 2018

Oct 29, 2018

BUY
$55.19 - $62.25 $1,324 - $1,494
24 Added 0.58%
4,163 $258,000
Q2 2018

Jul 26, 2018

BUY
$50.53 - $62.98 $1,414 - $1,763
28 Added 0.68%
4,139 $229,000
Q1 2018

Apr 19, 2018

BUY
$59.92 - $68.98 $1,318 - $1,517
22 Added 0.54%
4,111 $260,000
Q4 2017

Jan 25, 2018

BUY
$59.94 - $65.35 $1,378 - $1,503
23 Added 0.57%
4,089 $251,000
Q3 2017

Nov 01, 2017

BUY
$55.23 - $63.74 $224,565 - $259,166
4,066
4,066 $259,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Shayne & Co., LLC Portfolio

Follow Shayne & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shayne & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shayne & Co., LLC with notifications on news.